The ex-dividend date for Merck (NYSE:MRK) is tomorrow, June 13, 2013. Owners of shares as of market close today will be eligible for a dividend of 43 cents per share. At a price of $47.97 as of 9:30 a.m., the dividend yield is 3.5%.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- The ex-dividend date for Merck (NYSE: MRK) is tomorrow, June 13, 2013. Owners of shares as of market close today will be eligible for a dividend of 43 cents per share. At a price of $47.97 as of 9:30 a.m. ET, the dividend yield is 3.5%. The average volume for Merck has been 18.2 million shares per day over the past 30 days. Merck has a market cap of $146.33 billion and is part of the health care sector and drugs industry. Shares are up 16.2% year to date as of the close of trading on Tuesday. Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company has a P/E ratio of 24.7, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Merck as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Merck Ratings Report. See our dividend calendar or top-yielding stocks list. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..